Enlitic Inc. has announced a conditional placement to raise A$15 million through the issuance of new CDIs at a price of A$0.004 per CDI, alongside a proposed Convertible Notes conversion to streamline its financial structure. The funds, expected to enable the company to reach cashflow break-even, will be used for commercialization, R&D, sales expansion, and other corporate needs. An additional A$1 million is targeted through a Security Purchase Plan, with shareholder approvals required for these actions. A 10:1 share consolidation is also proposed post-placement and note conversion. The efforts aim to enhance Enlitic's position in the medical imaging sector, particularly with its SaaS-based Ensight offering.
Key Points
Enlitic Inc. announced a A$15 million Conditional Placement.
The Conditional Placement is priced at A$0.004 per CDI, which is a discount compared to previous trade prices.
The placement aims to fund operations until cashflow break-even and support commercialization efforts.
A Security Purchase Plan (SPP) is proposed to raise an additional A$1 million.
Conversion of existing Convertible Notes is proposed to simplify capital structure and eliminate debt.
Share consolidation of 10:1 is proposed following the Conditional Placement and note conversion.
The Conditional Placement and SPP require shareholder approval and are subject to certain conditions.
Funds will be allocated across R&D, marketing, strategic development, and other corporate functions.
Barrenjoey Markets Pty Limited is the Lead Manager and Bookrunner for the Conditional Placement.
Enlitic aims to expand its SaaS-based Ensight offering in healthcare settings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.